Literature DB >> 20839382

Prostate cancer. Nuclear irregularity is a predictor of clinical outcome.

Annette Fenner.   

Abstract

Entities:  

Year:  2010        PMID： 20839382     DOI： 10.1038/nrurol.2010.131

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy.

Authors:  Robert W Veltri; Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Alan W Partin
Journal:  Prostate       Date:  2010-09-01       Impact factor: 4.104
  1 in total
  1 in total

1.  Loss of VHL promotes progerin expression, leading to impaired p14/ARF function and suppression of p53 activity.

Authors:  Youn-Sang Jung; Su-Jin Lee; Sun-Hye Lee; Ji-Yun Chung; Youn Jin Jung; Sang Hyun Hwang; Nam-Chul Ha; Bum-Joon Park
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.